New directions in allergic diseases: mechanism-based anti-inflammatory therapies.
about
Solid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents.Bone marrow cell derived arginase I is the major source of allergen-induced lung arginase but is not required for airway hyperresponsiveness, remodeling and lung inflammatory responses in mice.Anti-inflammatory and Immune-regulatory Effects of Subcutaneous Perillae Fructus Extract Injections on OVA-induced Asthma in MiceImmunotherapy in atopic dermatitis.What are the most promising strategies for the therapeutic immunomodulation of allergic diseases?Molecular mechanisms of atopyDissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis.Chemokines and their receptors in the allergic airway inflammatory process.Tryptase as an inflammatory marker in allergic disease and asthma.Treatment of experimental asthma by decoy-mediated local inhibition of activator protein-1.Asthma and therapeutics: recombinant therapies in asthmaResistin-like molecule-beta is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung.Rosmarinic acid in perilla extract inhibits allergic inflammation induced by mite allergen, in a mouse model.Biological studies on the effect of estrogen on experimentally induced asthma in mice.Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma.Swedish translation and validation of the Pediatric Allergic Disease Quality of Life Questionnaire (PADQLQ).Allergen induced TFF2 is expressed by mucus-producing airway epithelial cells but is not a major regulator of inflammatory responses in the murine lung.In vitro evaluation of biospecific and pseudobiospecific ligands aimed at extracorporeal treatment for immunoglobulin E removal.Trefoil factor-2 is an allergen-induced gene regulated by Th2 cytokines and STAT6 in the lung.
P2860
Q31103106-391D3685-68F6-49C0-A6FF-194C0D8B8FDEQ33457721-3E3502EB-3C67-4EE3-9104-BD458E654A50Q33629873-B3318BF5-4F0F-4967-89AC-D7C6F74928C0Q34104585-3051B84B-AB59-494C-B610-F5B76D360FA9Q34190563-0BF185CF-925B-48D4-B4B0-2E660F31F6BAQ34510796-8699E8D9-2968-4318-8687-BEED20FC3B72Q35095605-479F89A6-6666-41E9-B083-022C2FEE0174Q37721300-1F892081-964D-45D4-8E3A-6BDFC96846A7Q37755301-F522669F-C26A-44AE-944B-A06435CFE29CQ38324836-6A73AAC5-DC47-45E2-A1D2-922333102558Q39433127-FFC1F119-5DA1-4699-9882-3414A0D87F99Q42827760-88EB36BD-722C-4369-B071-D5327DCA956DQ44935639-F10CAA2C-EF0A-4822-A229-16BC37FE0777Q45069419-E71EBAE7-CED9-4B10-A976-18146556DAD7Q47755798-233473EC-F2C8-46EB-BA50-FF14E7DFAFC6Q48782773-607AF460-87C0-4C81-AEC0-E4FD0872D897Q50473452-9745E97D-C43B-400F-B0F2-E0200A6EA54DQ51145484-1C713E08-9CF5-4FDB-A7A8-148BDB42A573Q51676937-998D57DC-B6F7-4665-9E7C-3FABD4A02C8C
P2860
New directions in allergic diseases: mechanism-based anti-inflammatory therapies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
New directions in allergic diseases: mechanism-based anti-inflammatory therapies.
@ast
New directions in allergic diseases: mechanism-based anti-inflammatory therapies.
@en
type
label
New directions in allergic diseases: mechanism-based anti-inflammatory therapies.
@ast
New directions in allergic diseases: mechanism-based anti-inflammatory therapies.
@en
prefLabel
New directions in allergic diseases: mechanism-based anti-inflammatory therapies.
@ast
New directions in allergic diseases: mechanism-based anti-inflammatory therapies.
@en
P356
P1476
New directions in allergic diseases: mechanism-based anti-inflammatory therapies.
@en
P2093
P356
10.1067/MAI.2000.107930
P407
P433
P577
2000-07-01T00:00:00Z